(Q37873829)

24 August 2017

1 reference

title

Oxidative stress and diabetic kidney disease (English)

1 reference

24 August 2017

0 references

Robert C Stanton

1

1 reference

24 August 2017

publication date

1 August 2011

1 reference

24 August 2017

published in

Current diabetes report

1 reference

24 August 2017

volume

11

1 reference

24 August 2017

issue

4

1 reference

24 August 2017

page(s)

330-336

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-011-0196-9

24 August 2017

exact match

0 references

cites work

Diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Nephropathy in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

NADPH oxidases and angiotensin II receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Activation of protein kinase C isoforms and its impact on diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Diabetic nephropathy: mechanisms of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Protein kinase C-beta inhibition for diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

AGE, RAGE, and ROS in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Aldose reductase in the etiology of diabetic complications: 2. Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Getting a notch closer to understanding diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Overexpression of Cu/Zn-superoxide dismutase and/or catalase in mice inhibits aorta smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

NADPH oxidases in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

NOX enzymes and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Normalizing NADPH oxidase contributes to attenuating diabetic nephropathy by the dual endothelin receptor antagonist CPU0213 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Diabetes, oxidative stress, and antioxidants: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Importance of glucose-6-phosphate dehydrogenase activity for cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Reduction of renal superoxide dismutase in progressive diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

Probucol delays progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-011-0196-9

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

21 January 2018

1 reference

12 December 2020

α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy

1 reference

12 December 2020

Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species

1 reference

12 December 2020

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

1 reference

12 December 2020

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

1 reference

12 December 2020

Pathogenesis of diabetic glomerulopathy: hemodynamic considerations

1 reference

12 December 2020

Oxidative stress in diabetic nephropathy

1 reference

12 December 2020

Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress

1 reference

12 December 2020

Genetics of diabetes complications

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Oxidative stress as a major culprit in kidney disease in diabetes

1 reference

12 December 2020

High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes

1 reference

12 December 2020

Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species

1 reference

12 December 2020

Reduced glutathione system: role in cancer development, prevention and treatment (review).

1 reference

12 December 2020

Relationship between low-normal blood pressure and kidney disease in type 1 diabetes

1 reference

12 December 2020

10.1007/S11892-011-0196-9

Identifiers

DOI

1 reference

24 August 2017

1 reference